RxDoctor Payments Data

Nicholas Katcher, MD

Family Medicine · Saginaw, MINPI 1497283329

Payments from drug & device makers

$304in general payments, 2019–2025

Across 19 payments — averaging $16.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$69
  • Pfizer$63
  • Astellas Pharma US Inc$43
  • Boehringer Ingelheim$36
  • Lilly USA, LLC$25
  • AstraZeneca$25
  • plus $43 from 3 others

What the payments were for

  • Food & beverage$29396%
  • Education$124%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$304 in reported general payments places this provider in the 50th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$43,915
Medicare patients
171
Services billed
493

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide95$103,761
JardianceEmpagliflozin78$88,063
EliquisApixaban48$61,199
Trelegy ElliptaFluticasone/Umeclidin/Vilanter67$59,836
TrulicityDulaglutide29$31,025
MounjaroTirzepatide24$25,660
XareltoRivaroxaban16$20,099
JanuviaSitagliptin Phosphate15$16,459
Tiotropium Bromide12$6,206
Fluticasone-SalmeterolFluticasone Propion/Salmeterol18$4,865
Incruse ElliptaUmeclidinium Bromide13$4,636
Atorvastatin Calcium275$3,701
Lantus SolostarInsulin Glargine,hum.Rec.Anlog28$3,494
Novolog FlexpenInsulin Aspart16$2,196
Sucralfate53$2,130

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$69$103,76195 claims
Boehringer IngelheimJardiance$36$88,06378 claims
PfizerEliquis$63$61,19948 claims
Lilly USA, LLCTrulicity, Mounjaro$25$56,68553 claims
MerckJanuvia$16$16,45915 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Saginaw

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →